Recursion Pharmaceuticals
clinical patient population large diagnosable and easy to identify large unmet need with significant cost burden disease overview difficile infection | Recursion Pharmaceuticals
Deck Type
Deck date
January 2023
Slide
121 of 143
Related slides by other companies
Investor Presentation
August 2023
Investor Conference
January 2023
Investor Presentation
August 2023
IPO
November 2020
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io